CME Group (CME) FY2015 results: revenue $3.3 billion, up 6.9% on the year
CME Group Inc. (CME) reported revenue of $3.3 billion for fiscal 2015, the year ended 31 December 2015, up 6.9% on the year before. Net income was $1.2 billion, up 10.6%, and diluted earnings per share $3.69. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2016.
Revenue
$3.3 billion
+6.9% on the year
FY2008FY2015
Operating margin
59.8%
56.8% a year earlier
FY2008FY2015
Net income
$1.2 billion
+10.6% on the year
FY2008FY2015
Diluted EPS
$3.69
+10.1% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
3,327
3,112
2,936
+6.9%
Operating income
1,989
1,768
1,637
+12.5%
Operating margin
59.8%
56.8%
55.8%
Pre-tax income
1,957
1,771
1,601
+10.5%
Income tax
710
644
623
+10.1%
Effective tax rate
36.3%
36.4%
38.9%
Net income
1,247
1,127
977
+10.6%
Net margin
37.5%
36.2%
33.3%
Diluted EPS
$3.69
$3.35
$2.92
+10.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
1,532
1,291
1,280
+18.7%
Capital expenditure
114
141
126
-18.8%
Free cash flow
1,418
1,151
1,155
+23.3%
Free cash flow margin
42.6%
37.0%
39.3%
Cash from investing
17.9
-199
190
Cash from financing
-1,224
-2,196
-606
Depreciation and amortisation
129
133
135
-2.6%
Share-based compensation
60.8
54.8
54.4
+10.9%
Buybacks
n/a
n/a
0.0
Dividends paid
1,343
1,497
599
-10.2%
Dividend per share
$4.90
$3.88
$4.40
+26.3%
Diluted shares, weighted
338m
336m
334m
+0.5%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
20,552
20,924
21,155
-1.8%
Non-controlling interest
n/a
0.0
5.7
Redeemable equity
n/a
n/a
0.0
Debt
2,229
2,108
2,857
+5.8%
Other liabilities
44,590
49,210
30,260
-9.4%
Total liabilities and equity
67,372
72,242
54,278
-6.7%
Fixed assets
492
509
513
-3.4%
Goodwill
7,569
7,569
7,569
0.0%
Intangible assets
2,538
2,637
2,741
-3.8%
Investments
72.5
74.7
68.4
-2.9%
Trading assets
55.9
55.1
49.6
+1.5%
Cash and equivalents
1,693
1,366
2,470
+23.9%
Receivables
358
341
303
+4.9%
Other assets
54,594
59,689
40,564
-8.5%
Total assets
67,372
72,242
54,278
-6.7%
10-K for the year ended 31 December 2015, filed 26 February 2016: the filing.